Tuhura Biosciences Inc (HURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,291 | -16,188 | -6,664 | -21,682 | -15,687 |
| Depreciation Amortization | 49 | 27 | 14 | 1,395 | 1,206 |
| Other Working Capital | -3,609 | 2,342 | 487 | 3,287 | 1,159 |
| Other Operating Activity | 4,778 | 2,832 | 1,425 | 2,273 | 1,193 |
| Operating Cash Flow | $-22,073 | $-10,987 | $-4,738 | $-14,728 | $-12,129 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,308 | -1,308 | -43 | -58 | -5,229 |
| Net Acquisitions | N/A | N/A | -1,108 | -5,995 | N/A |
| Investing Cash Flow | $-1,308 | $-1,308 | $-1,151 | $-6,052 | $-5,229 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 0 | 28,568 | 28,568 |
| Debt Repayment | -478 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 15,733 | 9,535 | 504 | 7,049 | 7,035 |
| Dividend Paid | -6 | -4 | -2 | N/A | N/A |
| Other Financing Activity | -1,828 | -1,381 | -1,050 | -5,844 | -2,315 |
| Financing Cash Flow | $13,421 | $8,150 | $-548 | $29,773 | $33,288 |
| Beginning Cash Position | 12,657 | 12,657 | 12,657 | 3,665 | 3,665 |
| End Cash Position | 2,697 | 8,513 | 6,220 | 12,657 | 19,596 |
| Net Cash Flow | $-9,960 | $-4,144 | $-6,437 | $8,992 | $15,931 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,073 | -10,987 | -4,738 | -14,728 | -12,129 |
| Capital Expenditure | -1,308 | -1,308 | -43 | -58 | -5,229 |
| Free Cash Flow | -23,381 | -12,294 | -4,781 | -14,786 | -17,357 |